Stocks and Investing Stocks and Investing
Tue, November 9, 2021

Gena Wang Maintained (ARCT) at Sell with Decreased Target to $31 on, Nov 9th, 2021


Published on 2024-10-27 18:34:39 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Sell with Decreased Target from $46 to $31 on, Nov 9th, 2021.

Gena has made no other calls on ARCT in the last 4 months.



There are 5 other peers that have a rating on ARCT. Out of the 5 peers that are also analyzing ARCT, 0 agree with Gena's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Gena


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $114 on, Wednesday, August 25th, 2021
  • Steven Seedhouse of "Raymond James" Downgraded from Hold to Sell on, Thursday, August 12th, 2021
  • Madhu Kumar of "Goldman Sachs" Downgraded from Hold to Strong Sell and Held Target at $29 on, Wednesday, August 11th, 2021
  • Brian Cheng of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $85 on, Tuesday, August 10th, 2021
  • Joel Beatty of "Baird" Downgraded from Hold to Sell on, Tuesday, August 10th, 2021
Contributing Sources